Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission
- 1 November 2020
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 52 (11-12) , 1676-1682
Abstract
Summary: Background: Histologic remission in ulcerative colitis (UC) patients may be associated with positive outcomes. It is unclear whether UC patients in endoscopic remission obtain additional benefit from achieving histologic remission.Aim: To evaluate the relationship between time to relapse and histological activity among UC patients in endoscopic remission.Methods: In this retrospective study using an observational database, we identified UC patients who had achieved endoscopic remission (Mayo endoscopic subscore 0). Index colonoscopy was the first colonoscopy when endoscopic remission was achieved. Histologic activity was classified as normal, inactive or active colitis. The primary outcome was time to relapse. Secondary outcomes included reasons for relapse and the association between baseline variables and risk of relapse. A Cox proportional hazards model evaluated baseline factors and the outcome of relapse.Results: We included 269 patients. The Kaplan‐Meier survival curve showed no significant difference between the presence or absence of histologic activity and time to relapse (log rank P = 0.85). There was no difference in time to clinical relapse of patients with histologically active colitis compared to inactive colitis (adjusted hazard ratio [AHR] 1.17, 95% CI 0.58‐2.32, P = 0.67]). 5‐aminosalicylate use (AHR 0.42, 95% CI 0.21‐0.82, P = 0.011), pancolitis (AHR 0.32, 95% CI 0.13‐0.75, P = 0.008), left‐sided colitis (AHR 0.46; 95% CI 0.22‐0.98; P = 0.044) and older age (AHR 0.96, 95% CI 0.94‐0.99, P = 0.002) were significantly associated with reduced time to clinical relapse.Conclusion: Histologic remission did not influence time to relapse in UC patients who had achieved endoscopic remission.Keywords
This publication has 32 references indexed in Scilit:
- An endoscopic Mayo score of 0 is associated with a lower risk of colectomy than a score of 1 in ulcerative colitisGut, 2014
- 5-Aminosalicylates Reduce the Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis: An Updated Meta-AnalysisPLOS ONE, 2014
- Systematic review with meta‐analysis: inflammatory bowel disease in the elderlyAlimentary Pharmacology & Therapeutics, 2014
- Mucosal healing in inflammatory bowel diseases: a systematic reviewGut, 2012
- Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative ColitisGastroenterology, 2011
- Patients With Late-Adult-Onset Ulcerative Colitis Have Better Outcomes Than Those With Early Onset DiseaseClinical Gastroenterology and Hepatology, 2010
- Importance of mucosal healing in ulcerative colitisInflammatory Bowel Diseases, 2010
- History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitisInflammatory Bowel Diseases, 2009
- A reproducible grading scale for histological assessment of inflammation in ulcerative colitisGut, 2000
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987